Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

ClearBridge Investments All Cap Growth 2025 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (ClearBridge Investments All Cap Growth)

Primary Source Intelligence • Q1 2025 Letter Analysis

ClearBridge Investments All Cap Growth Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, ClearBridge Investments All Cap Growth. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Positioning StanceConstructive

Market CapLarge Cap

GeographyUS

Digest Analysis

Quick Take

"ClearBridge All Cap Growth outperformed in Q1 as tariff chaos and AI concerns pressured mega caps. Strong stock selection and Magnificent Seven underweight drove outperformance."

Executive Summary

ClearBridge's All Cap Growth Strategy outperformed during Q1 2025 as growth indexes entered correction territory amid chaotic tariff introductions and fears of slowing U.S. economy and higher inflation. The Strategy benefited from strong diversified stock selection and an underweight to the Magnificent Seven, which largely underperformed except Meta. The emergence of DeepSeek, a Chinese AI model built with inferior chips at lower cost, questioned massive Gen AI capex and pressured Nvidia despite record results. Defensive holdings like Vertex Pharmaceuticals, UnitedHealth, Visa, and S&P Global provided stability, while newer positions Cintas and TJX held up well amid recession fears. The team added AppLovin for mobile advertising growth and Ares Management for private credit exposure, while exiting AbbVie and Charles River Labs. Looking ahead, they expect earnings growth broadening beyond technology to industrials and healthcare, positioning the portfolio for this shift while monitoring tariff risks on multinational holdings and consumer spending pressures.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

75%

CautiousHigh

High Conviction (75%)

High conviction evident in specific portfolio actions (adding two new positions, exiting two others), clear positioning rationale around Magnificent Seven underweight, and confident statements about market broadening thesis. Detailed analysis of individual holdings and strategic positioning demonstrates strong conviction in approach.

Growth Outlook

38%

BearishBullish

Neutral (38%)

The manager describes a challenging environment with growth indexes in correction territory, chaotic tariff introductions, and fears of slowing economy and higher inflation. However, they note the general health of the economy entering this cycle phase is strong, creating a mixed but slightly negative outlook.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

The portfolio maintained selective positioning with strategic additions (AppLovin, Ares) and exits (AbbVie, Charles River), showing measured risk-taking. The underweight to Magnificent Seven and focus on diversified holdings suggests cautious but constructive positioning.

Capital Deployment

20%

De-riskingDeploying

De-risking (20%)

Moderate deployment activity with two new positions added (AppLovin, Ares Management) while exiting two others (AbbVie, Charles River Labs). The language 'took advantage of recent volatility to add' suggests selective deployment, but no indication of major cash level changes or aggressive scaling.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The manager expresses confidence in their positioning for market broadening, expects earnings growth from industrials and healthcare to narrow the gap with technology, and believes they are well-positioned for heightened uncertainty, indicating constructive forward bias.

Language Signal

10%

BearishBullish

Bearish (10%)

Language includes both risk-aware terms (correction, chaos, fears, headwinds) and opportunity-focused terms (well-positioned, outperformed, strong selection). The balance slightly favors cautious optimism with phrases like 'well-positioned' and 'broadening market' offsetting risk language.

Perceived Risk

70%

Low RiskElevated

Elevated Risk (70%)

High risk awareness with explicit discussion of tariff headwinds to GDP growth, consumer spending pressures from inflation, and heightened uncertainty period. Manager actively monitoring risks to consumer sector and engaging with management teams about supply chain risks, indicating elevated risk perception.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Selective opportunity set with specific areas of focus (mobile advertising recovery, private credit growth, market broadening beyond mega caps). Manager sees opportunities in mid-cap plus companies and expects earnings growth broadening, but opportunities appear targeted rather than broad-based.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Medium to long-term orientation evident in positioning for market broadening theme, focus on secular tailwinds in private credit, and emphasis on durable compounder holdings. The expectation for 2025 earnings growth narrowing and positioning for cycle phases suggests patient, multi-quarter investment horizon.